Use of Hologic LOCalizer radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: experience of the first 150 cases in a UK breast unit

Lowes, Simon; Bell, Ashleigh; Milligan, Robert A.; Amonkar, Sunil; Leaver, A

doi:10.1016/j.crad.2020.08.014

Cited by 40 publications

(35 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Full texts were then examined for the 10 abstracts, which met the inclusion criteria for our review [ 10 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ]. One study (Tayeh et al) [ 10 ] was excluded since its results were part of a larger study that is already included in our analysis [ 19 ].…”

Section: Resultsmentioning

confidence: 99%

“…Therefore, nine studies were used in the final analysis. Seven cohort studies used to calculate the rates of successful placement, successful retrieval and re-excision in the final pooled analysis [ 13 , 14 , 15 , 16 , 17 , 18 , 19 ].…”

Section: Resultsmentioning

confidence: 99%

“…Five studies reported no complications [ 14 , 15 , 17 , 18 , 19 , 22 ]. One study reported a postoperative haematoma which was managed conservatively [ 13 ].…”

Section: Resultsmentioning

confidence: 99%

“…The number of patients in most of the primary studies was relatively low (<100). Only two studies included more than 100 patients [ 16 , 17 ]. Only one small study compared RFID with other wireless, radiation free technologies [ 20 ].…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review

Tayeh

Wazir

Mokbel

2021

Cancers

View full text Add to dashboard Cite

Wire-guided localisation (WGL) has been the gold-standard for localising non-palpable breast lesions before excision. Due to its drawbacks, various wireless alternatives have been developed, including LOCalizer™, which is based on radio-frequency identification (RFID) technology. In this systematic review, we consulted EMBASE, Medline and PubMed databases using appropriate search terms regarding the use of RFID technology in the localisation of occult breast lesions. Retrospective and prospective studies were included if they quoted the number of patients, rate of successful placement, retrieval rate, margin positivity rate and the re-excision rate. In addition, studies comparing RFID to WGL were also included and analysed separately. Seven studies were included in this systematic review spanning 1151 patients and 1344 tags. The pooled deployment rate was 99.1% and retrieval rate was 100%. Re-excision rate was 13.9%. One complication was identified. Two studies compared RFID with WGL (128 vs. 282 patients respectively). For both techniques the re-excision rate was 15.6% (20/128 vs. 44/282 respectively, p value is 0.995). Based on our review, LOCalizer™ is safe and non-inferior to WGL in terms of successful localisation and re-excision rates. However, further research is required to assess the cost effectiveness of this approach and its impact on the aesthetic outcome compared with WGL and other wire free technologies to better inform decision making in service planning and provision.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

“…Five studies reported no complications [ 14 , 15 , 17 , 18 , 19 , 22 ]. One study reported a postoperative haematoma which was managed conservatively [ 13 ].…”

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review

Tayeh

Wazir

Mokbel

2021

Cancers

View full text Add to dashboard Cite

show abstract

“…Other possible techniques are radar reflector-localization clips [55] and radiofrequency identification (RFID) tags [56,57], that have provided promising results for non-palpable lesion localization, while data on lymph node marking are limited. Table 4 shows potential advantages and disadvantages of various methods and Table 5 gives an overview of current evidence.…”

Section: Which Marking Technique Is Optimal?mentioning

confidence: 99%

Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study

Banys‐Paluchowski

Gasparri

Boniface

et al. 2021

Cancers

102

View full text Add to dashboard Cite

In the last two decades, surgical methods for axillary staging in breast cancer patients have become less extensive, and full axillary lymph node dissection (ALND) is confined to selected patients. In initially node-positive patients undergoing neoadjuvant chemotherapy, however, the optimal management remains unclear. Current guidelines vary widely, endorsing different strategies. We performed a literature review on axillary staging strategies and their place in international recommendations. This overview defines knowledge gaps associated with specific procedures, summarizes currently ongoing clinical trials that address these unsolved issues, and provides the rationale for further research. While some guidelines have already implemented surgical de-escalation, replacing ALND with, e.g., sentinel lymph node biopsy (SLNB) or targeted axillary dissection (TAD) in cN+ patients converting to clinical node negativity, others recommend ALND. Numerous techniques are in use for tagging lymph node metastasis, but many questions regarding the marking technique, i.e., the optimal time for marker placement and the number of marked nodes, remain unanswered. The optimal number of SLNs to be excised also remains a matter of debate. Data on oncological safety and quality of life following different staging procedures are lacking. These results provide the rationale for the multinational prospective cohort study AXSANA initiated by EUBREAST, which started enrollment in June 2020 and aims at recruiting 3000 patients in 20 countries (NCT04373655; Funded by AGO-B, Claudia von Schilling Foundation for Breast Cancer Research, AWOgyn, EndoMag, Mammotome, and MeritMedical).

show abstract

Diagnostic accuracy of de‐escalated surgical procedure in axilla for node‐positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta‐analysis

Song

Liang

et al. 2022

Cancer Medicine

View full text Add to dashboard Cite

show abstract

Use of Hologic LOCalizer radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: experience of the first 150 cases in a UK breast unit

Cited by 40 publications

References 9 publications

The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review

The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review

Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study

Diagnostic accuracy of de‐escalated surgical procedure in axilla for node‐positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta‐analysis

Contact Info

Product

Resources

About